{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:05:23Z","timestamp":1786993523425,"version":"build-2736575974"},"reference-count":37,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008672","name":"Wilhelm Sander-Stiftung","doi-asserted-by":"publisher","award":["2018.092.1"],"award-info":[{"award-number":["2018.092.1"]}],"id":[{"id":"10.13039\/100008672","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.jtct.2023.04.006","type":"journal-article","created":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T22:07:44Z","timestamp":1683324464000},"page":"457.e1-457.e10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["KIR2DS4 and Its Variant KIR1D in KIR-AA Genotype Donors Showed Differential Survival Impact in Patients with Lymphoid Disease after HLA-Matched Unrelated Hematopoietic Stem Cell Transplantation"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2656-9399","authenticated-orcid":false,"given":"Sowmya","family":"Gowdavally","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chrysanthi","family":"Tsamadou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Platzbecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Sala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9181-8067","authenticated-orcid":false,"given":"Thomas","family":"Valerius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5103-9966","authenticated-orcid":false,"given":"Nicolaus","family":"Kr\u00f6ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7669-3785","authenticated-orcid":false,"given":"Gerald","family":"Wulf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermann","family":"Einsele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenz","family":"Thurner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Schaefer-Eckart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Freitag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Casper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mareike","family":"D\u00fcrholt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Kaufmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Hertenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Ringhoffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Schmeller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9935-8042","authenticated-orcid":false,"given":"Christine","family":"Neuchel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Immanuel","family":"Rode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1732-9019","authenticated-orcid":false,"given":"Elisa Maria","family":"Amann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1222-6659","authenticated-orcid":false,"given":"Hubert","family":"Schrezenmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joannis","family":"Mytilineos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Fuerst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2023.04.006_bib0001","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/5250790","article-title":"Donor selection for allogenic hemopoietic stem cell transplantation: clinical and ethical considerations","volume":"2017","author":"Riezzo","year":"2017","journal-title":"Stem Cells Int"},{"key":"10.1016\/j.jtct.2023.04.006_bib0002","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.3389\/fimmu.2020.02022","article-title":"Influence of KIR and NK cell reconstitution in the outcomes of hematopoietic stem cell transplantation","volume":"11","author":"Gao","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtct.2023.04.006_bib0003","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1365-2567.2010.03398.x","article-title":"Structure\/function of human killer cell immunoglobulin-like receptors: lessons from polymorphisms, evolution, crystal structures and mutations","volume":"132","author":"Campbell","year":"2011","journal-title":"Immunology"},{"key":"10.1016\/j.jtct.2023.04.006_bib0004","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1182\/asheducation-2016.1.106","article-title":"Can we make a better match or mismatch with KIR genotyping?","volume":"2016","author":"Mehta","year":"2016","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"database issue","key":"10.1016\/j.jtct.2023.04.006_bib0005","first-page":"D1234","article-title":"IPD\u2014the Immuno Polymorphism Database","volume":"41","author":"Robinson","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jtct.2023.04.006_bib0006","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.1073\/pnas.080588597","article-title":"Plasticity in the organization and sequences of human KIR\/ILT gene families","volume":"97","author":"Wilson","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtct.2023.04.006_bib0007","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1182\/blood-2010-05-283051","article-title":"Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia","volume":"116","author":"Cooley","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.04.006_bib0008","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.humimm.2006.12.007","article-title":"Studies on the expression of the deleted KIR2DS4*003 gene product and distribution of KIR2DS4 deleted and nondeleted versions in different populations","volume":"68","author":"Middleton","year":"2007","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jtct.2023.04.006_bib0009","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1038\/leu.2008.108","article-title":"Association of KIR2DS4 and its variant KIR1D with leukemia","volume":"22","author":"Giebel","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.jtct.2023.04.006_bib0010","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.bbmt.2015.10.004","article-title":"KIR2DS4 and its variant KIR1D are associated with acute graft-versus-host disease, cytomegalovirus, and overall survival after sibling-related HLA-matched transplantation in patients with donors with KIR gene haplotype A","volume":"22","author":"Wu","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.04.006_bib0011","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1038\/bmt.2009.357","article-title":"The impact of KIR2DS4 alleles and the expression of KIR in the development of acute GVHD after unrelated allogeneic hematopoietic SCT","volume":"45","author":"Bao","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.04.006_bib0012","doi-asserted-by":"crossref","first-page":"e13728","DOI":"10.1111\/petr.13728","article-title":"The impact of donor full-length KIR2DS4 in the development of acute and chronic GVHD after unrelated allogeneic HSCT","volume":"24","author":"An","year":"2020","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jtct.2023.04.006_bib0013","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.humimm.2016.11.010","article-title":"The impact of KIR2DS4 gene on clinical outcome after hematopoietic stem cell transplantation","volume":"78","author":"Burek Kamenaric","year":"2017","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jtct.2023.04.006_bib0014","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1182\/blood-2008-07-171926","article-title":"Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia","volume":"113","author":"Cooley","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.04.006_bib0015","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/bmt.2011.110","article-title":"The EBMT Risk Score","volume":"47","author":"Gratwohl","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.04.006_bib0016","series-title":"The EBMT Handbook: Hematopoietic Stem Cell Transplantation and Cellular Therapies","article-title":"Statistical methods in HSCT and cellular therapies","author":"Iacobelli","year":"2019"},{"key":"10.1016\/j.jtct.2023.04.006_bib0017","first-page":"825","article-title":"1994 Consensus Conference on Acute GVHD Grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.04.006_bib0018","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1182\/blood-2009-03-208983","article-title":"Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD","volume":"114","author":"Vigorito","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.04.006_bib0019","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1182\/blood-2016-07-686642","article-title":"Classification systems for chronic graft-versus-host disease","volume":"129","author":"Lee","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.04.006_bib0020","series-title":"Modeling Survival Data: Extending the Cox Model. Statistics for Biology and Health","first-page":"39","article-title":"The Cox model","author":"Therneau","year":"2000"},{"key":"10.1016\/j.jtct.2023.04.006_bib0021","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1214\/aos\/1176350951","article-title":"A class of $K$-sample tests for comparing the cumulative incidence of a competing risk","volume":"16","author":"Gray","year":"1988","journal-title":"Ann Stat"},{"issue":"database issue","key":"10.1016\/j.jtct.2023.04.006_bib0022","doi-asserted-by":"crossref","first-page":"D784","DOI":"10.1093\/nar\/gku1166","article-title":"Allele frequency net 2015 update: new features for HLA epitopes, KIR and disease and HLA adverse drug reaction associations","volume":"43","author":"Gonz\u00e1lez-Galarza","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jtct.2023.04.006_bib0023","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1084\/jem.20051884","article-title":"Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function","volume":"203","author":"Yawata","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.jtct.2023.04.006_bib0024","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.humimm.2004.10.013","article-title":"Haplotype analysis of killer cell immunoglobulin-like receptor genes in 77 Korean families","volume":"66","author":"Whang","year":"2005","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jtct.2023.04.006_bib0025","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1038\/sj.leu.2403525","article-title":"Identification of natural killer cell receptor phenotypes associated with leukemia","volume":"18","author":"Verheyden","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.jtct.2023.04.006_bib0026","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/sj.leu.2405040","article-title":"NK cell receptors and their ligands in leukemia","volume":"22","author":"Verheyden","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.jtct.2023.04.006_bib0027","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00251-002-0463-7","article-title":"Definition of gene content for nine common group B haplotypes of the Caucasoid population: KIR haplotypes contain between seven and eleven KIR genes","volume":"54","author":"Uhrberg","year":"2002","journal-title":"Immunogenetics"},{"key":"10.1016\/j.jtct.2023.04.006_bib0028","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1182\/blood-2010-10-313791","article-title":"Novel associations between activating killer-cell immunoglobulin-like receptor genes and childhood leukemia","volume":"118","author":"Almalte","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.04.006_bib0029","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1084\/jem.20091010","article-title":"KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A*11 while diminishing avidity for HLA-C","volume":"206","author":"Graef","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.jtct.2023.04.006_bib0030","doi-asserted-by":"crossref","first-page":"12964","DOI":"10.1073\/pnas.1903781116","article-title":"Human NK cell receptor KIR2DS4 detects a conserved bacterial epitope presented by HLA-C","volume":"116","author":"Sim","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtct.2023.04.006_bib0031","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.bbmt.2010.03.004","article-title":"Donor KIR Genes 2DL5A, 2DS1 and 3DS1 are associated with a reduced rate of leukemia relapse after HLA-identical sibling stem cell transplantation for acute myeloid leukemia but not other hematologic malignancies","volume":"16","author":"Stringaris","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.04.006_bib0032","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1056\/NEJMoa1200503","article-title":"HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1","volume":"367","author":"Venstrom","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2023.04.006_bib0033","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1182\/blood-2010-08-264085","article-title":"Killer Ig-like receptor-mediated control of natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation","volume":"117","author":"Moretta","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.04.006_bib0034","first-page":"5580","article-title":"Decreased natural killer cell activity in children with untreated acute leukemia","volume":"43","author":"Nasrallah","year":"1983","journal-title":"Cancer Res"},{"key":"10.1016\/j.jtct.2023.04.006_bib0035","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.bcmd.2007.06.029","article-title":"NK cell alloreactivity and allogeneic hematopoietic stem cell transplantation","volume":"40","author":"Ruggeri","year":"2008","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.jtct.2023.04.006_bib0036","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1182\/blood-2004-09-3548","article-title":"Analysis of the receptor-ligand interactions in the natural killer-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: evidence for the involvement of the Poliovirus receptor (CD155) and Nectin-2 (CD112)","volume":"105","author":"Pende","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.04.006_bib0037","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3389\/fimmu.2013.00027","article-title":"The role of KIR genes and ligands in leukemia surveillance","volume":"4","author":"Babor","year":"2013","journal-title":"Front Immunol"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636723012368?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636723012368?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T08:59:54Z","timestamp":1778921994000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636723012368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S2666636723012368"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2023.04.006","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"KIR2DS4 and Its Variant KIR1D in KIR-AA Genotype Donors Showed Differential Survival Impact in Patients with Lymphoid Disease after HLA-Matched Unrelated Hematopoietic Stem Cell Transplantation","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2023.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}